Sleep-disordered Breathing After Solid Organ Transplantation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

Sleep-disordered breathing (SDB) describes a group of disorders in which partial or complete cessation of breathing occurs many times throughout the night, resulting in daytime sleepiness or fatigue that interferes with a person's ability to function and reduces quality of life. Transplantation has become an important treatment modality for end-stage organ failure. Transplant recipients are now living longer and, hence, develop chronic adverse medical conditions. Furthermore, transplantation is associated with weight gain. Despite the high prevalence of poor sleep and cardiovascular conditions among transplant patients, SDB is not well studied in these patients.

Eligibility criteria

Qualifiers

Patients 1 year after lung transplantation

Disqualifiers

Refusal of PSG

Medical contra-indication to perform PSG

Trial design

Treatments tested in this trial

  • No intervention - Diagnostic polysomnography at 1 year after lung transplantation

Treatment groups

300 Participants
are divided into 1 treatment group